What Factors Affect Outcome in the Treatment of Fracture-Related Infection?

This international, multi-center study investigated the effect of individual components of surgery on the clinical outcomes of patients treated for fracture-related infection (FRI). All patients with surgically treated FRIs, confirmed by the FRI consensus definition, were included. Data were collect...

Full description

Bibliographic Details
Main Authors: Martin McNally, Ruth Corrigan, Jonathan Sliepen, Maria Dudareva, Rob Rentenaar, Frank IJpma, Bridget L. Atkins, Marjan Wouthuyzen-Bakker, Geertje Govaert
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/7/946
_version_ 1797433961926885376
author Martin McNally
Ruth Corrigan
Jonathan Sliepen
Maria Dudareva
Rob Rentenaar
Frank IJpma
Bridget L. Atkins
Marjan Wouthuyzen-Bakker
Geertje Govaert
author_facet Martin McNally
Ruth Corrigan
Jonathan Sliepen
Maria Dudareva
Rob Rentenaar
Frank IJpma
Bridget L. Atkins
Marjan Wouthuyzen-Bakker
Geertje Govaert
author_sort Martin McNally
collection DOAJ
description This international, multi-center study investigated the effect of individual components of surgery on the clinical outcomes of patients treated for fracture-related infection (FRI). All patients with surgically treated FRIs, confirmed by the FRI consensus definition, were included. Data were collected on demographics, time from injury to FRI surgery, soft tissue reconstruction, stabilization and systemic and local anti-microbial therapy. Patients were followed up for a minimum of one year. In total, 433 patients were treated with a mean age of 49.7 years (17–84). The mean follow-up time was 26 months (range 12–72). The eradication of infection was successful in 86.4% of all cases and 86.0% of unhealed infected fractures were healed at the final review. In total, 3.3% required amputation. The outcome was not dependent on age, BMI, the presence of metalwork or time from injury (recurrence rate 16.5% in FRI treated at 1–10 weeks after injury; 13.1% at 11–52 weeks; 12.1% at >52 weeks: <i>p</i> = 0.52). The debridement and retention of a stable implant (DAIR) had a failure rate of 21.4%; implant exchange to a new internal fixation had a failure rate of 12.5%; and conversion to external fixation had a failure rate of 10.3% (adjusted hazard ratio (aHR) DAIR vs. Ext Fix 2.377; 95% C.I. 0.96–5.731). Tibial FRI treated with a free flap was successful in 92.1% of cases and in 80.4% of cases without a free flap (HR 0.38; 95% C.I. 0.14–1.0), while the use of NPWT was associated with higher recurrence rates (HR 3.473; 95% C.I. 1.852–6.512). The implantation of local antibiotics reduced the recurrence from 18.7% to 10.0% (HR 0.48; 95% C.I. 0.29–0.81). The successful treatment of FRI was multi-factorial. These data suggested that treatment decisions should not be based on time from injury alone, as other factors also affected the outcome. Further work to determine the best indications for DAIR, free flap reconstruction and local antibiotics is warranted.
first_indexed 2024-03-09T10:24:26Z
format Article
id doaj.art-9752accd876042e0a1e17b427dbbb4ff
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T10:24:26Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-9752accd876042e0a1e17b427dbbb4ff2023-12-01T21:49:09ZengMDPI AGAntibiotics2079-63822022-07-0111794610.3390/antibiotics11070946What Factors Affect Outcome in the Treatment of Fracture-Related Infection?Martin McNally0Ruth Corrigan1Jonathan Sliepen2Maria Dudareva3Rob Rentenaar4Frank IJpma5Bridget L. Atkins6Marjan Wouthuyzen-Bakker7Geertje Govaert8Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford OX3 9DU, UKBone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford OX3 9DU, UKDepartment of Trauma Surgery, University Medical Centre Groningen, University of Groningen, 9712 CP Groningen, The NetherlandsBone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford OX3 9DU, UKDepartment of Medical Microbiology, University Medical Centre Utrecht, 3584 CX Utrecht, The NetherlandsDepartment of Trauma Surgery, University Medical Centre Groningen, University of Groningen, 9712 CP Groningen, The NetherlandsBone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford OX3 9DU, UKDepartment of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, 9712 CP Groningen, The NetherlandsDepartment of Trauma Surgery, University Medical Centre Utrecht, 3584 CX Utrecht, The NetherlandsThis international, multi-center study investigated the effect of individual components of surgery on the clinical outcomes of patients treated for fracture-related infection (FRI). All patients with surgically treated FRIs, confirmed by the FRI consensus definition, were included. Data were collected on demographics, time from injury to FRI surgery, soft tissue reconstruction, stabilization and systemic and local anti-microbial therapy. Patients were followed up for a minimum of one year. In total, 433 patients were treated with a mean age of 49.7 years (17–84). The mean follow-up time was 26 months (range 12–72). The eradication of infection was successful in 86.4% of all cases and 86.0% of unhealed infected fractures were healed at the final review. In total, 3.3% required amputation. The outcome was not dependent on age, BMI, the presence of metalwork or time from injury (recurrence rate 16.5% in FRI treated at 1–10 weeks after injury; 13.1% at 11–52 weeks; 12.1% at >52 weeks: <i>p</i> = 0.52). The debridement and retention of a stable implant (DAIR) had a failure rate of 21.4%; implant exchange to a new internal fixation had a failure rate of 12.5%; and conversion to external fixation had a failure rate of 10.3% (adjusted hazard ratio (aHR) DAIR vs. Ext Fix 2.377; 95% C.I. 0.96–5.731). Tibial FRI treated with a free flap was successful in 92.1% of cases and in 80.4% of cases without a free flap (HR 0.38; 95% C.I. 0.14–1.0), while the use of NPWT was associated with higher recurrence rates (HR 3.473; 95% C.I. 1.852–6.512). The implantation of local antibiotics reduced the recurrence from 18.7% to 10.0% (HR 0.48; 95% C.I. 0.29–0.81). The successful treatment of FRI was multi-factorial. These data suggested that treatment decisions should not be based on time from injury alone, as other factors also affected the outcome. Further work to determine the best indications for DAIR, free flap reconstruction and local antibiotics is warranted.https://www.mdpi.com/2079-6382/11/7/946fracture-related infectionnon-unioninfectionfractureoutcomeDAIR
spellingShingle Martin McNally
Ruth Corrigan
Jonathan Sliepen
Maria Dudareva
Rob Rentenaar
Frank IJpma
Bridget L. Atkins
Marjan Wouthuyzen-Bakker
Geertje Govaert
What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
Antibiotics
fracture-related infection
non-union
infection
fracture
outcome
DAIR
title What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
title_full What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
title_fullStr What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
title_full_unstemmed What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
title_short What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
title_sort what factors affect outcome in the treatment of fracture related infection
topic fracture-related infection
non-union
infection
fracture
outcome
DAIR
url https://www.mdpi.com/2079-6382/11/7/946
work_keys_str_mv AT martinmcnally whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT ruthcorrigan whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT jonathansliepen whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT mariadudareva whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT robrentenaar whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT frankijpma whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT bridgetlatkins whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT marjanwouthuyzenbakker whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection
AT geertjegovaert whatfactorsaffectoutcomeinthetreatmentoffracturerelatedinfection